Milton H Dalbow

Title: The Innovative Contributions of Milton H. Dalbow

Introduction

Milton H. Dalbow is a notable inventor based in Springdale, PA, who has made significant contributions to the field of diagnostic testing. With a total of 3 patents to his name, Dalbow's work primarily focuses on the detection of human chorionic gonadotropin (hCG), a hormone that can indicate the presence of cancer.

Latest Patents

Dalbow's latest patents include a "Kit for Detecting Human Chorionic Gonadotropin" and a "Cell Test for Detecting Human Chorionic Gonadotropin." Both inventions are designed as diagnostic tools to identify hCG levels in cells, which can serve as evidence of cancer. The process involves treating the subject's cells with antiserum specific to the beta-subunit of hCG, followed by dividing the treated cells into two portions. Each portion is then treated with antiserum to the gamma globulin of the host animal, with one portion conjugated to fluorescein and the other to peroxidase. A positive cancer diagnosis is confirmed only when both tests yield positive results.

Career Highlights

Dalbow is associated with International Radioimmune Systems, Inc., where he continues to innovate in the field of medical diagnostics. His work has paved the way for more accurate and reliable cancer detection methods, contributing to advancements in healthcare.

Collaborations

Some of his notable coworkers include Hernan F. Acevedo and Malcolm Slifkin, who have collaborated with him on various projects within the company.

Conclusion

Milton H. Dalbow's contributions to the field of diagnostic testing highlight the importance of innovation in medical science. His patents reflect a commitment to improving cancer detection methods, ultimately benefiting patient care and outcomes.